Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthias Schwebe"'
Autor:
Stefan Oswald, Markus Grube, Judith V. Monzel, Thomas Budde, Eberhard Scheuch, Ralf Ewert, Sabine Ameling, Elke Hammer, Karina Bonitz, Matthias Schwebe, Henry W. S. Schroeder, Sandra Bien-Möller, Kathleen Schult, Heyo K. Kroemer, Susanne Budde, Axel Poesch
Publikováno v:
Biochemical Pharmacology. 94:109-129
The clinical efficiency of the highly potent antitumor agent doxorubicin is limited by cardiotoxic effects. In a murine doxorubicin cardiotoxicity model, increased endothelin-1 (ET-1) expression and cardioprotective effects of the dual ET-1 blocker b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67adb6882e504d47327ed9c9b58eedce
https://doi.org/10.1016/j.bcp.2015.01.014
https://doi.org/10.1016/j.bcp.2015.01.014
Autor:
Heyo K. Kroemer, Judith V. Monzel, Markus Grube, Thomas Budde, Matthias Schwebe, Sandra Bien-Möller, Gabriele Jedlitschky, Henriette E. Meyer zu Schwabedissen, Dieter Lütjohann
Publikováno v:
Biochemical pharmacology. 144
The anthracycline-mediated cardiotoxicity is still not completely understood. To examine the impact of cholesterol metabolism and transport in this context, cholesterol and oxysterol levels as well as the expression of the cholesterol transporters AB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a1941232341eea6c7c9a8aec765ad3
https://pubmed.ncbi.nlm.nih.gov/28807695
https://pubmed.ncbi.nlm.nih.gov/28807695
Publikováno v:
PharmacoEconomics German Research Articles. 10:17-28
Background and Objective: Adverse drug reactions (ADR) are appreciably harmful or unpleasant effects, resulting from an intervention related to the use of a medicinal product, with a high burden for patients and considerable economic consequences. Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::157a323a04f83b1caa347d3f82033121
https://doi.org/10.1007/bf03320775
https://doi.org/10.1007/bf03320775
Autor:
Sandra Bien, Susann Herzog, Christoph A. Ritter, Juliane Niessen, Sabine Ameling, Uwe Völker, Janine Hussner, Matthias Schwebe, Leif Steil, Elke Hammer, Henry Ws Schroeder, Heyo K. Kroemer
Publikováno v:
Molecular Pharmacology. 81:679-688
Activation of the immune system is a way for host tissue to defend itself against tumor growth. Hence, treatment strategies that are based on immunomodulation are on the rise. Conventional cytostatic drugs such as the anthracycline doxorubicin can al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1635cec77628859dbac32e2866727223
https://doi.org/10.1124/mol.111.075994
https://doi.org/10.1124/mol.111.075994
Autor:
Heyo K. Kroemer, Markus Grube, Jeanette Haney, Matthias Schwebe, Carsten Tschöpe, Alexander Staudt, Sandra Bien, Gabriele Jedlitschky, Thomas Budde, Alexander Riad, Stephan B. Felix
Publikováno v:
Journal of Pharmaceutical Sciences. 100:3951-3958
Doxorubicin is a frequently used anticancer drug, but its use is restricted due to the occurrence of severe side effects, namely strong cardiotoxicity. It is known from cancer cells that doxorubicin enhanced the expression of its efflux pump P-glycop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d5478ff36e7298c31bb335e63258e6
https://doi.org/10.1002/jps.22622
https://doi.org/10.1002/jps.22622
Autor:
Heyo K. Kroemer, Sandra Bien, Ralf Ewert, Eberhard Scheuch, Stefan Oswald, Axel Poesch, Susanne Schlensack, Matthias Schwebe, Werner Siegmund
Publikováno v:
D63. SIGNAL TRANSDUCTION: MEMBRANE RECEPTORS AND INTRACELLULAR PATHWAYS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9278dcc9d456ffbce8e7d656f2c25561
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6366
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6366